Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer

Role of Comorbidity on Survival after Radiotherapy and Chemotherapy for Nonsurgically Treated Lung Cancer

(2015) Anders Mellemgaard et al.   Journal of Thoracic Oncology

Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling

(2014) Xiangrong Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway

(2014) Jing-Tao Zhang et al.   BMC CANCER

Intersection of AHR and Wnt Signaling in Development, Health, and Disease

(2014) Andrew Schneider et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Wnt signaling pathway pharmacogenetics in non-small cell lung cancer

(2014) D J Stewart et al.   PHARMACOGENOMICS JOURNAL

An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control

(2014) H. Clevers et al.   SCIENCE

Targeting the β-catenin nuclear transport pathway in cancer

(2014) Cara Jamieson et al.   SEMINARS IN CANCER BIOLOGY

Role of Radiotherapy in Metastatic Non-Small Cell Lung Cancer

(2014) Sergio L. Faria   Frontiers in Oncology

Immunotherapy for Lung Cancer: Has it Finally Arrived?

(2014) Ahmed A. Mostafa et al.   Frontiers in Oncology

Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer

(2013) Min Tan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways

(2013) Long Zhang et al.   CANCER SCIENCE

Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells

(2013) Birdal Bilir et al.   Journal of Translational Medicine

Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations

(2013) Sun A Kim et al.   MODERN PATHOLOGY

Norcantharidin Induced DU145 Cell Apoptosis through ROS-Mediated Mitochondrial Dysfunction and Energy Depletion

(2013) Bo Shen et al.   PLoS One

Effect of Norcantharidin on the Human Breast Cancer Bcap-37 Cells

(2012) Dongwu Liu et al.   CONNECTIVE TISSUE RESEARCH

Wnt inhibitory factor-1 regulates glioblastoma cell cycle and proliferation

(2012) Jun Wu et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Potential CanonicalWntPathway Activation in High-Grade Astrocytomas

(2012) Rebecca Schüle et al.   TheScientificWorldJOURNAL

Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway

(2011) Shujing Liu et al.   CANCER BIOLOGY & THERAPY

Inhibitory effects of norcantharidin against human lung cancer cell growth and migration

(2010) Jinling Luan et al.   CYTOTECHNOLOGY

Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas

(2010) Zhuanyi Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production

(2010) Hui-Fen Liao et al.   TOXICOLOGY IN VITRO

Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect

(2009) Yu-Jen Chen et al.   LIFE SCIENCES